0001179110-16-017812.txt : 20160119
0001179110-16-017812.hdr.sgml : 20160118
20160119160722
ACCESSION NUMBER: 0001179110-16-017812
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160114
FILED AS OF DATE: 20160119
DATE AS OF CHANGE: 20160119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Innoviva, Inc.
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502389600
MAIL ADDRESS:
STREET 1: 951 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: THERAVANCE INC
DATE OF NAME CHANGE: 20020207
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WITEK THEODORE L JR
CENTRAL INDEX KEY: 0001612452
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 161348407
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgar.xml
FORM 4 -
X0306
4
2016-01-14
0
0001080014
Innoviva, Inc.
INVA
0001612452
WITEK THEODORE L JR
951 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Sr. VP & Chief Scientific Off.
Common Stock
2016-01-14
4
A
0
92587
0
A
165554
D
Includes 49,293 shares of common stock underlying a time-based restricted stock unit award (RSU). Twenty-five percent of the shares subject to the RSU shall vest on February 20, 2017, and 6.25% on May 20, 2017, 6.25% on August 20, 2017, 6.25% on November 20, 2017, 6.25% on February 20, 2018, 6.25% on August 20, 2018 and the remaining 37.5% on November 20, 2018, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
Includes shares of common stock granted pursuant to a performance-based restricted stock unit award (PSU). The shares vest pursuant to the PSU over a two-year and a 32-month performance period upon, and subject to a formula related to, the Issuer's achievement of certain levels of total shareholder return (TSR). The "target" number of shares that may vest is 23,147, but the actual number of shares that may vest will range from 0 to 46,294 shares based on the Issuer's TSR over the performance periods. Subject to achievement of the performance-based vesting conditions, (i) two-thirds of the shares eligible to vest based on achievement for the two-year performance period will vest on February 20, 2018 and the remaining one-third of such shares will vest on November 20, 2018 and (ii) the shares eligible to vest based on achievement for the 32-month performance period will vest on November 20, 2018, in each case, (continued in Footnote 3)
(continued from Footnote 2) provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
Includes 1,538 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan (ESPP) on November 15, 2015.
/s/ Theodore L. Witek, Jr.
2016-01-19